| Abstract Scope |
Development of biocompatible nanocarriers that can transport anti-tumor drugs in the body represent a major challenge of precision medicine. For any systemically administered drug, the transport to the site of interest is inhibited by various physiological barriers, which reduces or even blocks the therapeutic efficiency of molecular drugs. Therefore, advanced drug-delivery systems are needed to overcome biological barriers.
In this context, hollow silica (SiO2) and metal oxide nanoparticles functionalized with receptor-targeting ligands are promising drug-carriers to transport higher amounts of therapeutic payloads and to reduce any undesired off-site effects. Moreover, hollow nanoparticles can incorporate more than one drug enabling theranostic and theraregenerative approaches. This talk will discuss the potential benefits of inorganic nanoparticles towards precision drug delivery.
|